top of page
Search


Study Finds Association Between Chronic Cannabis Use and Cardiovascular Dysfunction
In a study published in JAMA Cardiology , researchers found chronic cannabis use—whether through smoking or THC-infused edibles—is associated with impaired vascular function, even among young and otherwise healthy adults. Healthy vascular function allows blood vessels to dilate properly, deliver oxygen efficiently, and help regulate key processes within the circulatory system. When vascular function is impaired, blood vessels are less able to expand, which can reduce blood fl
Mar 30


House Energy and Commerce Committee Holds Hearing on Legislation Focused on Combating Addiction
On March 26, 2026, the House Energy and Commerce Committee held a hearing titled “Policies to Protect Our Communities from Illicit Drug Threats.” The hearing discussed 14 bills that aim to reduce overdoses and improve substance use prevention, treatment, and recovery services and addiction research. In the hearing, members of Congress agreed on a bipartisan basis that addiction should be treated as a disease using community-based care. House members highlighted that communit
Mar 27


April 2026 Alcohol Awareness Month
Alcohol Awareness Month is a time to raise awareness and increase understanding of how alcohol use impacts our health and communities. In the United States, alcohol contributes to more than 178,000 deaths each year, making it one of the leading preventable causes of death. In 2024 alone, nearly 28 million Americans ages 12 and older (1 in 10 people) met the criteria for an alcohol use disorder. Excessive alcohol use is also linked to seven different types of cancer and more t
Mar 27


Over 300 Organizations Join APF in Calling on Congress to Fund the Second Chance Act
Addiction Policy Forum joined 330 national, state, and local organizations in support of continued funding of the Second Chance Act in the Fiscal Year 2027 Commerce, Justice, Science, and Related Agencies Appropriations bill. The sign-on letter urges Congress to continue funding for Second Chance Act recidivism reduction and reentry programs. Second Chance Act programs provide individuals reentering the community with services, including housing, job training, education, sub
Mar 25


Treating Depression Early in Treatment May Improve Methamphetamine Use Disorder Outcomes
Methamphetamine use disorder (MUD) continues to pose a growing public health challenge in the United States. Despite rising rates of use and overdose deaths, there are currently no FDA-approved medications for treating MUD. Prior studies have shown that naltrexone (used to treat opioid and alcohol use disorders) and bupropion (an antidepressant) have independently been effective in MUD treatment. In a 2021 landmark clinical trial (ADAPT-2), researchers found that combining t
Mar 24


DEA Targets Emerging Substance Threat with Bromazolam Scheduling
On March 18, 2026, the Drug Enforcement Administration (DEA) announced that it has temporarily placed bromazolam, a synthetic benzodiazepine, into Schedule I of the Controlled Substances Act due to increasing reports of trafficking and misuse. According to the DEA, bromazolam is often used to manufacture counterfeit Xanax tablets and has become one of the most commonly identified benzodiazepines in illicit drug seizures. The agency determined the substance has a high potentia
Mar 24
bottom of page
